These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37669710)

  • 1. Potential mechanisms of action of resveratrol in prevention and therapy for mental disorders.
    Menegas S; Keller GS; Possamai-Della T; Aguiar-Geraldo JM; Quevedo J; Valvassori SS
    J Nutr Biochem; 2023 Nov; 121():109435. PubMed ID: 37669710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol ameliorates depressive disorder through the NETRIN1-mediated extracellular signal-regulated kinase/cAMP signal transduction pathway.
    Wang F; Wang J; An J; Yuan G; Hao X; Zhang Y
    Mol Med Rep; 2018 Mar; 17(3):4611-4618. PubMed ID: 29328454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and biological functions of resveratrol in psychiatric disorders: a review of recent evidence.
    Shayganfard M
    Cell Biosci; 2020 Nov; 10(1):128. PubMed ID: 33292508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of resveratrol on mitochondrial function in the hippocampus improves inflammation-induced depressive-like behavior.
    Chen WJ; Du JK; Hu X; Yu Q; Li DX; Wang CN; Zhu XY; Liu YJ
    Physiol Behav; 2017 Dec; 182():54-61. PubMed ID: 28964807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer's disease from bench to bedside.
    Islam F; Nafady MH; Islam MR; Saha S; Rashid S; Akter A; Or-Rashid MH; Akhtar MF; Perveen A; Md Ashraf G; Rahman MH; Hussein Sweilam S
    Mol Neurobiol; 2022 Jul; 59(7):4384-4404. PubMed ID: 35545730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease.
    Rahman MH; Akter R; Bhattacharya T; Abdel-Daim MM; Alkahtani S; Arafah MW; Al-Johani NS; Alhoshani NM; Alkeraishan N; Alhenaky A; Abd-Elkader OH; El-Seedi HR; Kaushik D; Mittal V
    Front Pharmacol; 2020; 11():619024. PubMed ID: 33456444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol suppresses neuroinflammation in the experimental paradigm of autism spectrum disorders.
    Bhandari R; Kuhad A
    Neurochem Int; 2017 Feb; 103():8-23. PubMed ID: 28025035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective Properties of Resveratrol and Its Derivatives-Influence on Potential Mechanisms Leading to the Development of Alzheimer's Disease.
    Wiciński M; Domanowska A; Wódkiewicz E; Malinowski B
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress.
    Chiang MC; Nicol CJ; Cheng YC
    Neurochem Int; 2018 May; 115():1-10. PubMed ID: 28989083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review.
    Lam NSK; Long XX; Li X; Saad M; Lim F; Doery JC; Griffin RC; Galletly C
    Biomed Pharmacother; 2022 Feb; 146():112541. PubMed ID: 34953391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health benefits of resveratrol: Evidence from clinical studies.
    Singh AP; Singh R; Verma SS; Rai V; Kaschula CH; Maiti P; Gupta SC
    Med Res Rev; 2019 Sep; 39(5):1851-1891. PubMed ID: 30741437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol and Alzheimer's Disease: Mechanistic Insights.
    Ahmed T; Javed S; Javed S; Tariq A; Šamec D; Tejada S; Nabavi SF; Braidy N; Nabavi SM
    Mol Neurobiol; 2017 May; 54(4):2622-2635. PubMed ID: 26993301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effects of resveratrol in Alzheimer disease pathology.
    Rege SD; Geetha T; Griffin GD; Broderick TL; Babu JR
    Front Aging Neurosci; 2014; 6():218. PubMed ID: 25309423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the molecular mode of action of trans-resveratrol in the Porphyromonas gingivalis lipopolysaccharide challenged neuronal cell model.
    Bahar B; Singhrao SK
    Mol Biol Rep; 2021 Jan; 48(1):147-156. PubMed ID: 33289908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol neuroprotection in stroke and traumatic CNS injury.
    Lopez MS; Dempsey RJ; Vemuganti R
    Neurochem Int; 2015 Oct; 89():75-82. PubMed ID: 26277384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Nutrients and Prevention of Alzheimer's Disease.
    Chauhan PS; Yadav D; Arukha AP
    CNS Neurol Disord Drug Targets; 2022; 21(3):217-227. PubMed ID: 33820525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol as a therapeutic agent for neurodegenerative diseases.
    Sun AY; Wang Q; Simonyi A; Sun GY
    Mol Neurobiol; 2010 Jun; 41(2-3):375-83. PubMed ID: 20306310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.